Efficacy of the Marlatt cognitive-behavioral model on decreasing relapse and craving in women with methamphetamine dependence: A clinical trial
The DOI matches its Crossref record; 26 of the 28 references it cites were found in a registry or an index.
Abstract
Methamphetamine use is now a global concern, which warrants a thorough assessment of the effectiveness of its different treatment modalities. To evaluate the efficacy of the Marlatt cognitive-behavioral model on decreasing the rate of relapse and craving in women with methamphetamine dependence, we conducted the present quasi-experimental study with a pretest–posttest and control group design in which 80 women with methamphetamine dependence who referred to Farabi Hospital of Kermanshah were chosen through convenience sampling and randomly allocated to two groups of intervention and control. Before and after the intervention, the members of both groups completed the Craving Belief Questionnaire (by Clark and Beck) and the Desire for Drug Questionnaire (by Franklin et al.). The results showed that in the intervention group, the Marlatt cognitive-behavioral treatment led to decreased relapse and craving. Cognitive-behavioral therapy can, therefore, be a treatment option to diminish relapse and craving in individuals with methamphetamine dependence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors
Washton, A. M. (1986) · Journal of Studies on Alcohol · doi:10.15288/jsa.1986.47.260 · Cited by 2,527 · cited 3×
“One of the positive features of the Marlatt and Gordon approach compared with other protocols is its emphasis on emotions such as impulsivity, anxiety, depression, and anger as well as recognizing the outcomes of these emotions in drug-seeking behaviors, which – if done well – confers an efficient prevention of cravin…”
BackgroundInfluentialMagill, M., & Ray, L. A. (2009) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2009.70.516 · Cited by 694 · cited 1×
“…for the effective alleviation of craving in this treatment modality in patients with methamphetamine dependence is that it raises awareness among them about their previous problematic reactions at the time of craving for drugs (Barrowclough et al., 2009; Brown et al., 2006; Magill & Ray, 2009).”
BackgroundCognitive Behavioral Therapy for Substance Use Disorders
McHugh, R. K., Hearon, B. A., & Otto, M. W. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.012 · Cited by 626 · cited 1×
“This finding is in agreement with the results reported by Ashouri and Mollazadeh (2008), McHugh et al. (2010), and George (1989).”
ResultWitkiewitz, K., & Bowen, S. (2010) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0019172 · Cited by 453 · cited 1×
“It severely affects the brain dopamine system and, thus, creates an extremely high desire for its repeated use, resulting in a vicious cycle of use-cessation and increased rates of lapse and relapse (Breese, Sinha, & Heilig, 2011; Witkiewitz & Bowen, 2010).”
BackgroundTheories of drug craving, ancient and modern
Drummond, D. C. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.961333.x · Cited by 450 · cited 1×
“The effects of a previously used substance are discernible among patients (Drummond, 2001; Eliason & Amodia, 2007).”
BackgroundInitial validation of two opiate craving questionnaires
Franken, I. H. A., Hendriks, V. M., & van den Brink, W. (2002) · Addictive Behaviors · doi:10.1016/s0306-4603(01)00201-5 · Cited by 307
Breese, G. R., Sinha, R., & Heilig, M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.007 · Cited by 261
Clinical and laboratory assessment of the subjective experience of drug craving
Rosenberg, H. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.06.002 · Cited by 251 · cited 2×
“Craving is a subjective experience of a severe desire or urge and powerfully predicts a return to all medications and used drugs consumed before (Abrams, 2000; Rosenberg, 2009).”
BackgroundCognitive function and nigrostriatal markers in abstinent methamphetamine abusers
Johanson, C.-E., Frey, K. A., Lundahl, L. H., Keenan, P., Lockhart, N., Roll, J., Galloway, G. P., Koeppe, R. A., Kilbourn, M. R., Robbins, T., et al. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0330-6 · Cited by 233
Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users
Chang, L., Ernst, T., Speck, O., Patel, H., DeSilva, M., Leonido-Yee, M., & Miller, E. N. (2002) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(02)00004-5 · Cited by 224 · cited 1×
“Methamphetamine has had the highest rate of use among all used substances in recent years (Chang et al., 2002).”
Background
Research works printed but not linked: 5
- Ashori, A., & Molazade, J. (2008). The effectiveness of cognitive-behavioral group therapy in preventing recurrence and improving the mental health of addicted people. Journal of Clinical Psychology and Personality, 1(34), 1–12.
- 10.1080/09652140020016941 · doi:10.1080/09652140020016941
- George, W. (1989). Marlatt and Gordon’s relapse prevention model: A cognitive-behavioral approach to understanding and preventing relapse. Journal of Chemical Dependency Treatment, 2(2), 125–152.
- Mohamadkhani, S.H., Sadeghi, N., Farzad, V. (2011). Negative excitement alive model, central beliefs, material beliefs, tempting ideas, and emotion settlement by back to consumption. Quarterly Journal of Advanced Psychological Research, 6(23), 159–183.
- Range, B. P, & Marlatt, G. A. (2008). Cognitive-behavioral therapy for alcohol and drug use disorders. Braz J Psychiatr, 30(Suppl 2), s88-95.
Cited by
Non-pharmacological interventions for methamphetamine use disorder: a systematic review
AshaRani, P., Hombali, A., Seow, E., Ong, W. J., Tan, J. H., & Subramaniam, M. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108060 · Cited by 143
Kaviyani, F., Khorrami, M., Heydari, H., & Namvar, M. (2023) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-023-00548-9 · Cited by 18
“Introduction Psychotropic drugs, including methamphetamine, are the most commonly used illegal drugs worldwide [1].”
BackgroundHersi, M., Corace, K., Hamel, C., Esmaeilisaraji, L., Rice, D., Dryburgh, N., Skidmore, B., Garber, G., Porath, A., Willows, M., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292745 · Cited by 13
Mhaidat, I., Taherian, M. R., Nazari, S. S. H., Mosavi-Jarrahi, A., Yeganeh, H., Al‐Yateem, N., Marzouqi, A. M. A., & Rahman, S. A. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-067115 · Cited by 14
Klein, T. N., Terry, D. R., & Peck, B. (2022) · Journal of Addictive Diseases · doi:10.1080/10550887.2023.2165870 · Cited by 7
Metadata
- Authors
- Abdoli, N., Farnia, V., Salemi, S., Tatari, F., Juibari, T. A., Alikhani, M., & Basanj, B.
- Affiliations
- Kermanshah University of Medical Sciences (IR)
- Corresponding author
- Salemi, Safora
- Venue
- Journal of Substance Use
- Publisher
- Informa UK Limited
- Published
- 2018-12-07
- Volume
- 24
- Issue
- 2
- Pages
- 229-232
- ISSN
- 1465-9891 (ISSN-L)
- 1475-9942
- OpenAlex
- W2905046366
- Cited by
- 10
- References
- 28
- Citations by year
- 2025: 1 · 2023: 4 · 2022: 1 · 2021: 2 · 2020: 2
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Substance Use (publishedVersion)
- Funders
- Substance Abuse Prevention Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran (Substance Abuse Prevention Research Center, Kerman)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- methamphetamine dependence, relapse prevention, drug craving, women, cognitive behavioral therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of the Marlatt cognitive-behavioral model on decreasing relapse and craving in women with methamphetamine dependence: A clinical trial. https://app.cochat.ai/papers/10.1080/14659891.2018.1549279
- The paper
- Abdoli, N., Farnia, V., Salemi, S., Tatari, F., Juibari, T. A., Alikhani, M., & Basanj, B. (2019). Efficacy of the Marlatt cognitive-behavioral model on decreasing relapse and craving in women with methamphetamine dependence: A clinical trial. Journal of Substance Use. https://doi.org/10.1080/14659891.2018.1549279
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.